Watch DERM. Know when insiders buy.
One email the day a filing lands. Free.
DERM
Journey Medical Corp
7.09
−0.36 −4.83%
USD · close Sep 10
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
46
WATCH · shorts 46
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $81.9MP/E —DIV YIELD —FCF YIELD —REV TTM $68.2M +20.9%NET INCOME −$6.1MNET CASH $171K52W 4.39 – 9.26SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $18.5M | +23.3% | 66.8% | $456K | −$312K | — | -0.01 | −$1.7M | — | — | Aug 12 |
| Q1 2026 · Mar 31 | $16M | +21.5% | 61.0% | −$1.5M | −$2.2M | — | -0.08 | $2.9M | — | — | May 13 |
| Q4 2025 · Dec 31derived | $16.1M | +18.1% | — | −$443K | −$1.2M | −182.0% | -0.04 | −$6.3M | — | — | Mar 26 |
| Q3 2025 · Sep 30 | $17.6M | +20.5% | — | −$1.5M | −$2.3M | — | -0.09 | −$2.4M | — | — | Nov 12 |
| Q2 2025 · Jun 30 | $15M | +1.0% | 67.1% | −$2.9M | −$3.8M | — | -0.16 | −$942K | — | — | Aug 12 |
| Q1 2025 · Mar 31 | $13.1M | +0.8% | 63.5% | −$3.3M | −$4.1M | — | -0.18 | −$2.8M | — | — | May 13 |
| Q4 2024 · Dec 31derived | $13.6M | −10.7% | 83.6% | $2.2M | $1.5M | — | 0.08 | $2.2M | — | — | Mar 26 |
| Q3 2024 · Sep 30 | $14.6M | −57.6% | 63.9% | −$2.9M | −$2.4M | −114.2% | -0.12 | −$1.2M | — | — | Nov 12 |
| Q2 2024 · Jun 30 | $14.9M | — | 56.0% | −$2.9M | −$3.4M | — | -0.17 | −$5.2M | — | — | Aug 12 |
| Q1 2024 · Mar 31 | $13M | — | 47.7% | −$10.1M | −$10.4M | — | -0.53 | −$5M | — | — | May 15 |
| Q4 2023 · Dec 31derived | $15.3M | — | 85.3% | −$2.1M | −$2.1M | — | -0.12 | −$16.5M | $0 | −$16.5M | Mar 27 |
| Q3 2023 · Sep 30 | $34.5M | — | 81.4% | $17.2M | $16.8M | — | 0.80 | $18.7M | $0 | $18.7M | Nov 12 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $61.9M | 66.2% | −$8.2M | −$11.4M | -18.5% | -0.47 | −$12.4M | — | — | — | — |
| FY2024 · to Dec 31 | $56.1M | 62.8% | −$13.7M | −$14.7M | -26.1% | -0.72 | −$9.1M | $15M | −$24.1M | — | — |
| FY2023 · to Dec 31 | $79.2M | 71.1% | −$2.1M | −$3.9M | -4.9% | -0.21 | $5.2M | $5M | $240K | — | — |
| FY2022 · to Dec 31 | $73.7M | 58.2% | −$27.5M | −$29.6M | -40.2% | -1.69 | −$13.5M | $20M | −$33.5M | — | — |
| FY2021 · to Dec 31 | $63.1M | 49.2% | −$34.9M | −$44M | -69.7% | -4.32 | −$2.2M | — | — | — | — |
| FY2020 · to Dec 31 | $44.5M | 67.2% | $7.9M | $5.3M | 11.9% | 0.49 | $5.1M | — | — | — | — |
Every number comes from Journey Medical Corp's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.